- TEVA Stock Page
Teva Pharmaceutical Industries Ltd. (NASDAQ-GS:TEVA)
Last Update: 17 minutes ago
| Change: | 1.95 (4.42%) |
| Last Trade: | 46.04 |
| Prev Close: | 44.09 |
| Share Volume: | 11,908,230 |
| Market Cap: | 37.38B |
| EPS (Earnings per share): | 2.14 |
| P/E (Price/earning ratio): | 20.60 |
| P/B (Price/book ratio): | 2.60 |
| Stock Price History | |
|---|---|
| Beta: | 0.07 |
| 52 week change: | 1.90% |
| 52 week high: | 50.00 |
| 52 week low: | 40.16 |
| 50 day moving avarage: | 44.32 |
| 200 day moving avarage: | 46.07 |
| Dividends | |
| Ex dividend date: | May 13, 2008 |
| Dividend yield: | 1.00% |
| Dividend rate: | 0.45 |
| Share Statistics | |
| Avarage 10 day volume: | 14,859,869 |
| Shares outstanding: | 812,000,000 |
| Short interest date: | Jun 25, 2008 |
| Short shares: | 21,240,461 |
| Short ratio: | 3.40 |
| Short % of float: | N/A |
| Today | 5d | 1m | 3m | 6m | 1y | 5y |
Company Profile
Sector: Healthcare
Industry: Drugs
Mfr/mkt/dist pharmaceutical & veterinarian prods
A global pharmaceutical company, which develops, produces and markets generic drugs covering all major treatment categories.
TEVA Headlines
-
12 hours ago
Teva Completes Acquisition of Bentley Pharmaceuticals -
Yesterday at 11:11 ET
Teva Introduces First Generic Lamictal(R) Tablets in the United States -
Jul 18 at 2:25 ET
Teva and Barr Invites Public to Listen to Webcast -
Jul 18 at 7:04 ET
Teva to Acquire Barr -
Jul 18 at 7:00 ET
Teva to Acquire Barr -
Jul 15 at 10:12 ET
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod -
Jul 14 at 5:04 ET
ADAGIO Phase III Top Line Data to be Presented at 12th Congress of European Federation of Neurological Societies -
Jul 14 at 3:48 ET
Teva to Report Second Quarter 2008 Financial Results on July 29, 2008 -
Jul 11 at 10:15 ET
Teva Comments on Paragraph IV Filing for COPAXONE(R); Intends to File Lawsuit against Generic Filer for Patent Infringement -
Jul 07 at 2:15 ET
Teva Provides Update on FORTE Trial